United States: Update To New CME Rule On Disruptive Trading Practices Summary Chart

Last Updated: September 23 2014
Article by Sohair A. Aguirre, Neal E. Kumar, Anthony M. Mansfield and Paul J. Pantano, Jr.

Most Read Contributor in United States, September 2018

On August 28, 2014, the Chicago Mercantile Exchange Inc., the Board of Trade of the City of Chicago, the New York Mercantile Exchange, Inc., and the Commodity Exchange, Inc. (collectively, the "CME") submitted a notice of a rule adoption to the Commodity Futures Trading Commission (the "CFTC") regarding new Rule 575, titled "Disruptive Practices Prohibited." Rule 575 became effective September 15, 2014. The CME also issued Market Regulation Advisory Notice RA1405-5 ("CME MRAN") which, with new Rule 575, provides regulatory guidance on various types of prohibited disruptive order entry and trading practices. On September 11, 2014, the Futures Industry Association ("FIA") hosted a webinar with staff from the CME to discuss new Rule 575 and the CME MRAN. This Clients & Friends Memo updates our previous memo on this topic based on FIA's webinar. In addition, on September 15, 2014, CME issued an updated MRAN with "minor modifications" based on CME's discussions with the CFTC. The updated MRAN did not change the September 15, 2014 effective date.

The prohibited disruptive trading practices specified in new Rule 575 will supplement existing CME exchange rules including Rules 432.B.2, 432.Q, and 432.T.1 During FIA's webinar, the CME emphasized that Rule 575 is a codification of CME's existing rules and is designed to provide guidance as opposed to establishing new substantive obligations. Therefore, it is possible, but we believe unlikely, that the CME may pursue "disruptive" conduct that predates September 15, 2014 under Rule 432. Although the CME reminded market participants that new Rule 575 is not an exhaustive list of trading practices that could violate exchanges rules and that market participants still could face liability under the more general requirements in CME Rule 432, CME said that it "did their best" to incorporate disruptive trading practices in Rule 575. Rules 432 and 575 do not completely overlap, so market participants should remember that they still need to comply with Rule 432.The CME MRAN notes that Rule 575 prohibits certain of the disruptive trading practices prohibited under Section 4c(a) of the Commodity Exchange Act ("CEA Prohibited Trading Practices"). The CEA Prohibited Trading Practices are:

  • violating bids or offers;
  • demonstrating intentional or reckless disregard for the orderly execution of transactions during the closing period; and
  • conduct that is commonly known to the trade as "spoofing" (bidding or offering with the intent to cancel the bid or offer before execution).

The CFTC previously issued interpretive guidance concerning the CEA Prohibited Trading Practices.2 Set forth below is a table that summarizes the most significant aspects of the new CME Rule 575, additional guidance from the CME MRAN, and comments on the practical impact of the provisions of the new CME Rule.

CME Rule Text CME Guidance Notes
CME Rule 575. All orders must be entered for the purpose of executing bona fide transactions. Additionally, all non-actionable messages must be entered in good faith for legitimate purposes.
  • The CME will consider many factors when evaluating whether specific conduct violated CME Rule 575, including the specific factors listed in response to Q1 of the CME MRAN. The September 15, 2014 update to the MRAN added "the number of orders" to the non-exhaustive list factors CME may consider.
  • Rule 575 applies to intentional conduct (and in the case of orderly trading (Rule 575.D), to both intentional and reckless conduct). According to the CME MRAN, "where the conduct was such that it more likely than not was intended to produce a prohibited disruptive consequence without justification, intent may be found. Claims of ignorance, or lack of knowledge, are not acceptable defenses to intentional or reckless conduct. Recklessness has been commonly defined as conduct that 'departs so far from the standards of ordinary care that it is very difficult to believe the actor was not aware of what he or she was doing.'"3
  • Rule 575 applies to all open outcry and electronic trading activity, including all market states (pre-opening, closing period, and all trading sessions).

    • The CME defines the "closing period" as "the period during which transactions, bids, and offers are reviewed for purposes of informing settlement price determinations. The 'closing period' may also refer to the period when various cash instruments close, commonly referred to as the 'Cash Close.'"4
    • Neither Rule 575 nor the CME MRAN define "bona fide transactions", "good faith" or "legitimate purposes." The CME guidance regarding prohibited practices should provide market participants with a helpful starting place to develop compliance controls that are reasonably designed to prevent violations of Rule 575.
    • Even if a trade(s) is bona fide, it may violate the CME's prohibition on disorderly trading (e.g., numerous trades entered for bona fide and legitimate purposes that are executed during a small window of the closing period). See below discussion on Rule 575.D.
    • To prove intent, CME Staff expect to rely on circumstantial evidence, which is consistent with the approach taken by the CFTC and other self-regulatory organizations.
  • Neither Rule 575 nor the CME MRAN define "bona fide transactions", "good faith" or "legitimate purposes." The CME guidance regarding prohibited practices should provide market participants with a helpful starting place to develop compliance controls that are reasonably designed to prevent violations of Rule 575.
  • Even if a trade(s) is bona fide, it may violate the CME's prohibition on disorderly trading (e.g., numerous trades entered for bona fide and legitimate purposes that are executed during a small window of the closing period). See below discussion on Rule 575.D.
  • To prove intent, CME Staff expect to rely on circumstantial evidence, which is consistent with the approach taken by the CFTC and other self-regulatory organizations.
CME Rule 575.A. No person shall enter or cause to be entered an order with the intent, at the time of order entry, to cancel the order before execution or to avoid execution.
  • The CME MRAN states that the CFTC identifies this prohibited trade practice as "spoofing," which includes submitting and canceling multiple bids/offers to create a misleading perception of market depth or to artificially move prices.
  • Although the CME does not identify factors specific to the prohibition on entering orders with the intent to cancel, the following factors from A1 of the CME MRAN appear most relevant to this issue:

    • Whether the market participant's intent was to induce others to trade when they otherwise would not;
    • Whether the market participant's intent was to affect a price rather than to change his position;
    • Whether the market participant's intent was to create misleading market conditions;
    • The ability of the market participant to manage the risk associated with the order(s) if fully executed;
    • The change in the best offer price, best bid price, last sale price, or Indicative Opening Price that results from the entry of the order.
    • The CME did not establish a safe harbor for the amount of time that an order must be exposed to the market to demonstrate that it was not a disruptive trade practice.5
    • The CME continues to permit market participants to modify or cancel orders, provided that there was an intent to enter a bona fide transaction at the time the order was submitted.6
    • Although unintentional, accidental, or "fat-finger," orders do not constitute disruptive trading under Rule 575; such activity may violate Rule 432.Q, which governs acts detrimental to the welfare of the exchange.
    • A partial fill of an order may indicate that the order was entered in good faith, but it does not establish a safe harbor from liability under Rule 575.
    • A market participant may enter orders to obtain "queue positioning" in the order book and subsequently cancel those orders based on changing market conditions, provided there are no other indicia of disruptive trading.7
    • Like the CEA's prohibition on spoofing, the CME's prohibition also requires a showing of specific intent. To demonstrate that such intent existed, the CME will evaluate a number of factors described further in the previous column. In addition, market participants should ensure that their communications do not lead to improper inferences after the fact.
    • During the FIA webinar, the CME emphasized that intent must be established at the time of order entry, which, according to the CME, is more specific than the CFTC's guidance on the CEA Prohibited Trading Practices.
    • The prohibition on spoofing also applies to resting orders that are later modified to avoid execution.
  • Like the CEA's prohibition on spoofing, the CME's prohibition also requires a showing of specific intent. To demonstrate that such intent existed, the CME will evaluate a number of factors described further in the previous column. In addition, market participants should ensure that their communications do not lead to improper inferences after the fact.
  • During the FIA webinar, the CME emphasized that intent must be established at the time of order entry, which, according to the CME, is more specific than the CFTC's guidance on the CEA Prohibited Trading Practices.
  • The prohibition on spoofing also applies to resting orders that are later modified to avoid execution.
CME Rule 575.B. No Person shall enter or cause to be entered an actionable or non-actionable message or messages with intent to mislead other market participants.
  • "Misleading" implies a general requirement not to act in violation of just and equitable principles of trade.
  • This section of the Rule prohibits a market participant from entering orders or messages with the intent of creating the false impression of market depth or market interest. The CME likely will find intent where the purpose of the conduct was, for example, to induce another market participant to engage in market activity.8
  • The CME defines an "actionable" message as a "message[s] that can be accepted by another party or otherwise lead to the execution of a trade." "Non-actionable" messages are "messages submitted to the [exchange] that relate to a non-actionable event" (e.g., requests for quotes).9
  • Although the CME does not identify factors specific to the prohibition on entering orders with the intent to cancel, the following factors from A1 of the CME MRAN appear most relevant to this issue:

    • Whether the market participant's intent was to induce others to trade when they otherwise would not;
    • Whether the market participant's intent was to create misleading market conditions;
    • The effect on other market participants; and
    • The market participant's historical pattern of activity.
    • Although CME Rule 575.B is not specifically covered under the CEA Prohibited Trading Practices, the CEA's prohibition on spoofing likely applies to this type of conduct as well. The CFTC has provided guidance that "spoofing" includes the following types of practices:

      • overloading the quotation system of a registered entity;
      • delaying another person's execution of trades;
      • creating an appearance of false market depth; and
      • creating artificial price movements upwards or downwards.
      • In addition, the CFTC could rely on its fraud-based manipulation authority to prosecute these types of trading activities.
      • The CME views the prohibition on spoofing in CME Rule 575.B as broader than the CFTC's disruptive trading practices guidance because the CME Rule also applies to non-actionable messages.
  • Although CME Rule 575.B is not specifically covered under the CEA Prohibited Trading Practices, the CEA's prohibition on spoofing likely applies to this type of conduct as well. The CFTC has provided guidance that "spoofing" includes the following types of practices:

    • overloading the quotation system of a registered entity;
    • delaying another person's execution of trades;
    • creating an appearance of false market depth; and
    • creating artificial price movements upwards or downwards.
  • In addition, the CFTC could rely on its fraud-based manipulation authority to prosecute these types of trading activities.
  • The CME views the prohibition on spoofing in CME Rule 575.B as broader than the CFTC's disruptive trading practices guidance because the CME Rule also applies to non-actionable messages.
CME Rule 575.C. No Person shall enter or cause to be entered an actionable or non-actionable message or messages with intent to overload, delay, or disrupt the systems of the Exchange or other market participants.
  • The CME MRAN refers to this type of conduct as "quote stuffing practices," which include submitting bids/offers to overload the quotation system and submitting bids/offers to delay another person's execution of the trade.
  • Although the CME does not identify factors specific to the prohibition on entering orders with the intent to cancel, the following factors from A1 of the CME MRAN appear most relevant to this issue:

    • Whether the market participant's intent was to create misleading market conditions;
    • Market conditions in the impacted market(s) and related markets;
    • The effect on other market participants;
    • The market participant's order entry and cancellation activity;
    • The size of the order(s) relative to market conditions at the time the order(s) was placed;
    • The size of the order(s) relative to the market participant's position and/or capitalization; and
    • The duration between, and frequency of, non-actionable messages.
    • This prohibited practice also is a specific intent violation. The CME must prove that the person intended to "overload, delay, or disrupt the systems of the Exchange or other market participants."
    • As noted above, the CFTC has expressly provided guidance that conduct that: (1) delays another person's execution of trades; (2) or overloads the quotation system of a registered entity" violates the CEA's prohibition on spoofing.
  • This prohibited practice also is a specific intent violation. The CME must prove that the person intended to "overload, delay, or disrupt the systems of the Exchange or other market participants."
  • As noted above, the CFTC has expressly provided guidance that conduct that: (1) delays another person's execution of trades; (2) or overloads the quotation system of a registered entity" violates the CEA's prohibition on spoofing.
CME Rule 575.D. No person shall enter or cause to be entered an actionable or non-actionable message with intent to disrupt, or with reckless disregard for the adverse impact on, the orderly conduct of trading or the fair execution of transactions.
  • The CME may evaluate whether conduct is intended to disrupt the orderly conduct of trading or whether it demonstrates a reckless disregard for orderly trading within "the context of the specific instrument, market conditions, and other circumstances present at the time in question."10
  • The CME relies on guidance from the CFTC in determining whether there was orderly conduct or the fair execution of transactions: "[A]n orderly market may be characterized by, among other things, parameters such as a rational relationship between consecutive prices, a strong correlation between price changes and the volume of trades, levels of volatility that do not dramatically reduce liquidity, accurate relationships between the price of a derivative and the underlying such as a physical commodity or financial instrument, and reasonable spreads between contracts for near months and for remote months."11
  • The CME expects market participants to be cognizant of the market characteristics of the products they trade to ensure their activity does not result in market disruptions. The size of an order, in and of itself, may be deemed to violate Rule 575 "if the entry results in disorderliness in the markets."12
  • The CME may deem orders entered for the purpose of "igniting momentum" to violate Rule 757 if the conduct was reckless.13
  • "Flipping" orders also are prohibited. The CME MRAN defines "flipping" as "the entry of orders or trades for the purpose of causing turns of the market and the creation of volatility and/or instability."14 Although market participants may change their view of the market, flipping activity is not allowed.
  • CME Rule 575.D employs a reckless standard similar to the CEA's prohibition on intentional or reckless disregard for the orderly execution of transactions during the closing period.
  • Market participants should be familiar with, and cognizant of, the condition of the market in which they trade a product (e.g., liquid, illiquid, congested) to help ensure that their orders are not disruptive.
  • The CFTC has said that the recklessness standard includes "conduct that departs so far from the standards of ordinary care that it is very difficult to believe the actor was not aware of what he or she was doing."15
  • Although the CEA prohibits intentional or reckless disregard for the orderly execution of transactions during the closing period, Rule 575 applies to all market trading periods, including the pre-opening period, the closing period, and all trading sessions. As noted above, the CME (and the CFTC) may deem even a bona fide trade as disorderly.

Footnotes

1. Rule 432.B.2 prohibits engaging in conduct or proceedings inconsistent with just and equitable principles of trade. Rule 432.Q prohibits commission of an act that is detrimental to the interest or welfare of the Exchange or to engage in any conduct which tends to impair the dignity or good name of the Exchange. Rule 432.T prohibits engaging in "dishonorable or uncommercial conduct."

2. See Antidisruptive Practices Authority, 78 Fed. Reg. 31890 (May 28, 2013).

3. CME MRAN A16 (quoting Drexel Burnham Lambert, Inc. v. CFTC, 850 F.2d 478, 742 (D.C. Cir. 1988)).

4. CME MRAN A15.

5. See CME MRAN A3.

6. See CME MRAN A4.

7. See CME MRANA10.

8. CME MRAN A2.

9. CME MRAN A12.

10. CME MRAN A13.

11. CME MRAN A13 (quoting Antidisruptive Practices Authority, 78 Fed. Reg. at 31,895-96).

12. CME MRAN A14.

13. CME MRAN A17.

14. CME MRAN A18.

15. Antidisruptive Practices Authority, 78 Fed. Reg. at 31,895.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions